High levels of uPA and PAI-1 predict a good response to anthracyclines
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2010
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Anthracyclines (MeSH)
- Antibiotics, Antineoplastic (MeSH)
- Biomarkers, Tumor (MeSH)
- Breast Neoplasms (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Plasminogen Activator Inhibitor 1 (MeSH)
- Predictive Value of Tests (MeSH)
- Research Design (MeSH)
- Urokinase-Type Plasminogen Activator (MeSH)